# Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy

> **NCT00152919** · PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 100 (estimated)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Meloxicam

## Key facts

- **NCT ID:** NCT00152919
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152919, "Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00152919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*